7.
Prognostic factors | Univariate | Multivariate | |||||
HR | 95% CI | P | HR | 95% CI | P | ||
DFS, disease-free survival; AC/ASC, adenocarcinoma/adenosquamous carcinoma; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis; LVSI, lymphovascular space invasion; HR, hazard ratio; 95% CI, 95% confidence interval. | |||||||
Age at diagnosis (year) (≥45 vs. <45) | 1.274 | 0.491–3.303 | 0.617 | – | – | – | |
BMI (kg/m2) (≥24 vs. <24) | 1.068 | 0.412–2.770 | 0.891 | – | – | – | |
FIGO stage (Ib vs. IIa) | 0.721 | 0.165–3.157 | 0.662 | – | – | – | |
Tumor size (cm) (≤4 vs.>4) | 0.513 | 0.197–1.335 | 0.163 | – | – | – | |
Differentiation (G1–G2 vs. G3) | 0.363 | 0.134–0.981 | 0.037 | 0.460 | 0.163–1.299 | 0.135 | |
LNM (+ vs. –) | 2.480 | 0.915–6.727 | 0.065 | – | – | – | |
Stromal invasion (≥1/2 vs. <1/2) | 0.692 | 0.226–2.124 | 0.517 | – | – | – | |
LVSI (+ vs. –) | 3.411 | 1.297–8.969 | 0.008 | 3.411 | 1.297–8.969 | 0.013 |